ArticleBMJ open respiratory research2022

Antibody responses and risk factors associated with impaired immunological outcomes following two doses of BNT162b2 COVID-19 vaccination in patients with chronic pulmonary diseases.

Zitta Barrella Harboe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.